For many life sciences start-ups, bringing on a GC early can be a strategic advantage. An experienced GC can help shape the company’s legal and operational foundation from day one, reducing reliance ...

Return on Engagement (ROE) is a call to action to better capture the multifaceted value of patient engagement.

PHARMAP 2026 provides the platform for a key industry conversation: how leading pharmaceutical companies are further ...

Senju Pharma has launched a new drug for dry eye disease (DED) in Japan, Avarept, which is the first drug in the TRPV1 antagonist class to reach the market. Licensed from fellow Japanese drugmaker ...

Researchers in the US have said that advances in therapeutics are outpacing the development of diagnostics to guide their use, due to policy gaps and payment barriers around the world. The team, from ...

A landmark study in China has shown that a base-editing therapy developed by CorrectSequence Therapeutics achieved stellar ...

Roche is paying $20 million upfront to secure rights to two degrader-antibody conjugates (DACs), developed by longtime ...

Boehringer Ingelheim has amended its partnership with Click Therapeutics on a digital therapeutic (DTx) for schizophrenia, ...

Anthropic has continued its push into the healthcare sector by acquiring New York start-up Coefficient Bio, a specialist in applying AI to drug discovery that was set up last year, but until now has ...

Investors looking for a quick turnaround in the fortunes of Bayer are likely to be disappointed by chief executive Bill Anderson's assessment of the next couple of years as he delivers the group's ...

The NHS in England will make Novo Nordisk's Wegovy available to around 1.2 million people in order to reduce their risk of heart attacks and strokes. New guidance from reimbursement authority NICE ...

Routine genomic testing could correct well-established disparities in breast cancer survival rates between white and Black women, according to a new study. Black women have a 5% lower incidence of ...